A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR

Retrovirology

Volumn 6, Issue , 2009, Pages

  Zhou, Tao ^a   Han, Yanxing ^a   Dang, Ying ^a   Wang, Xiaojun ^a   Zheng, Yong Hui ^a  

^a Michigan State University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3H; CALNEXIN; CYTIDINE DEAMINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; APOBEC3 PROTEIN, HUMAN; CYTOSINE DEAMINASE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; VIF PROTEIN;

ARTICLE; CELL CLONE; CELL LINE; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS RESISTANCE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

CALNEXIN; CELL LINE; CYTOSINE DEAMINASE; GENE EXPRESSION REGULATION; GENE PRODUCTS, VIF; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 65749106717     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-31     Document Type: Article

References (39)

1. Foley GE Lazarus H Farber S Uzman BG Boone BA McCarthy RE Continuous Culture Of Human Lymphoblasts From Peripheral Blood Of A Child With Acute Leukemia Cancer 1965, 18:522-529. 10.1002/ 1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J 14278051
2. Gabuzda DH Lawrence K Langhoff E Terwilliger E Dorfman T Haseltine WA Sodroski J Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes J Virol 1992, 66(11):6489-6495. 240141 1357189
3. vonSchwedler U Song J Aiken C Trono D Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells J Virol 1993, 67(8):4945-4955. 237882 8331734
4. NaraPL Hatch WC Dunlop NM Robey WG Arthur LO Gonda MA Fischinger PJ Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody AIDS Res Hum Retroviruses 1987, 3(3):283-302. 10.1089/aid.1987.3.283 3481271
5. FolksT Benn S Rabson A Theodore T Hoggan MD Martin M Lightfoote M Sell K Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus Proc Natl Acad Sci USA 1985, 82(13):4539-4543. 391138 2989831 10.1073/pnas.82.13.4539
6. Howell DN Andreotti PE Dawson JR Cresswell P Natural killing target antigens as inducers of interferon: Studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line J Immunol 1985, 134(2):971-976. 3871222
7. Han Y Wang X Dang Y Zheng YH APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication PLoS Pathog 2008, 4(7):e1000095. 2435275 18604271 10.1371/journal.ppat.1000095
8. Sheehy AM Gaddis NC Choi JD Malim MH Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 2002, 418(6898):646-650. 10.1038/nature00939 12167863
9. Jarmuz A Chester A Bayliss J Gisbourne J Dunham I Scott J Navaratnam N An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 Genomics 2002, 79(3):285-296. 10.1006/geno.2002.6718 11863358
10. Goila-Gaur R Strebel K HIV-1 Vif, APOBEC, and intrinsic immunity Retrovirology 2008, 5:51. 2443170 18577210 10.1186/1742-4690-5-51
11. Bishop KN Holmes RK Sheehy AM Davidson NO Cho SJ Malim MH Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins Curr Biol 2004, 14(15):1392-1396. 10.1016/j.cub.2004.06.057 15296758
12. Dang Y Wang X Esselman WJ Zheng YH Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family J Virol 2006, 80(21):10522-10533. 1641744 16920826 10.1128/JVI.01123-06
13. Doehle BP Schafer A Cullen BR Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif Virology 2005, 339(2):281-288. 10.1016/j.virol.2005.06.005 15993456
14. Liddament MT Brown WL Schumacher AJ Harris RS APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo Curr Biol 2004, 14(15):1385-1391. 10.1016/j.cub.2004.06.050 15296757
15. Wiegand HL Doehle BP Bogerd HP Cullen BR A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins Embo J 2004, 23(12):2451-2458. 423288 15152192 10.1038/sj.emboj.7600246
16. Zheng YH Irwin D Kurosu T Tokunaga K Sata T Peterlin BM Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J Virol 2004, 78(11):6073-6076. 415831 15141007 10.1128/ JVI.78.11.6073-6076.2004
17. Dang Y Siew LM Wang X Han Y Lampen R Zheng YH Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication J Biol Chem 2008, 283(17):11606-11614. 2430661 18299330 10.1074/jbc.M707586200
18. Harari A Ooms M Mulder LC Simon V Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H J Virol 2009, 83(1):295-303. 10.1128/JVI.01665-08 18945781
19. OhAinle M Kerns JA Li MM Malik HS Emerman M Antiretroelement activity of APOBEC3H was lost twice in recent human evolution Cell Host Microbe 2008, 4(3):249-259. 10.1016/j.chom.2008.07.005 18779051
20. Tan L Sarkis PT Wang T Tian C Yu XF Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1 Faseb J 2008, 23(1):279-287. 10.1096/fj.07-088781 18827027
21. Kidd JM Newman TL Tuzun E Kaul R Eichler EE Population stratification of a common APOBEC gene deletion polymorphism PLoS Genet 2007, 3(4):e63. 1853121 17447845 10.1371/journal.pgen.0030063
22. OhAinle M Kerns JA Malik HS Emerman M Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H J Virol 2006, 80(8):3853-3862. 1440450 16571802 10.1128/JVI.80.8.3853-3862.2006
23. Dang Y Siew LM Zheng YH APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated J Biol Chem 2008, 283(19):13124-13131. 2430655 18326044 10.1074/jbc.M708728200
24. Yu X Yu Y Liu B Luo K Kong W Mao P Yu XF Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 2003, 302(5647):1056-1060. 10.1126/science.1089591 14564014
25. Kao S Khan MA Miyagi E Plishka R Buckler-White A Strebel K The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity J Virol 2003, 77(21):11398-11407. 229358 14557625 10.1128/JVI.77.21.11398-11407.2003
26. Kao S Miyagi E Khan MA Takeuchi H Opi S Goila-Gaur R Strebel K Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells Retrovirology 2004, 1(1):27. 520834 15373943 10.1186/1742-4690-1-27
27. Santa-Marta M da Silva FA Fonseca AM Goncalves J HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation J Biol Chem 2005, 280(10):8765-8775. 10.1074/jbc.M409309200 15611076
28. Stremlau M Owens CM Perron MJ Kiessling M Autissier P Sodroski J The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys Nature 2004, 427(6977):848-853. 10.1038/nature02343 14985764
29. Neil SJ Zang T Bieniasz PD Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 2008, 451(7177):425-430. 10.1038/ nature06553 18200009
30. Han Y Wang X Dang Y Zheng YH Demonstration of a novel HIV-1 restriction phenotype from a human T cell line PLoS ONE 2008, 3(7):e2796. 2464712 18665212 10.1371/journal.pone.0002796
31. Scott JE Dawson JR MHC class I expression and transport in a calnexin-deficient cell line J Immunol 1995, 155(1):143-148. 7602092
32. Otteken A Moss B Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin J Biol Chem 1996, 271(1):97-103. 10.1074/jbc.271.1.97 8550632
33. Li Y Bergeron JJ Luo L Ou WJ Thomas DY Kang CY Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport Proc Natl Acad Sci USA 1996, 93(18):9606-9611. 38475 8790377 10.1073/pnas.93.18.9606
34. Mariani R Chen D Schröfelbauer B Navarro F König R Bollman B Münk C Nymark-McMahon H Landau NR Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 2003, 114(1):21-31. 10.1016/ S0092-8674(03)00515-4 12859895
35. Yu Q Chen D Konig R Mariani R Unutmaz D Landau NR APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication J Biol Chem 2004, 279(51):53379-53386. 10.1074/jbc.M408802200 15466872
36. Zennou V Bieniasz PD Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates Virology 2006, 349(1):31-40. 10.1016/j.virol.2005.12.035 16460778
37. Marin M Rose KM Kozak SL Kabat D HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat Med 2003, 9(11):1398-1403. 10.1038/nm946 14528301
38. Sheehy AM Gaddis NC Malim MH The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat Med 2003, 9(11):1404-1407. 10.1038/nm945 14528300
39. Stopak K de Noronha C Yonemoto W Greene WC HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol Cell 2003, 12(3):591-601. 10.1016/ S1097-2765(03)00353-8 14527406